Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State

Genetics in Medicine

Volumn 18, Issue 12, 2016, Pages 1235-1243

  Wasserstein, Melissa P ^a   Andriola, Mary ^b   Arnold, Georgianne ^c   Aron, Alan ^d   Duffner, Patricia ^e   Erbe, Richard W ^f   Escolar, Maria L ^c   Estrella, Lissette ^d   Galvin Parton, Patricia ^b   Iglesias, Alejandro ^g   Kay, Denise M ^h   Kronn, David F ⁱ   Kurtzberg, Joanne ^j   Kwon, Jennifer M ^k   Langan, Thomas J ^e   Levy, Paul A ^l   Naidich, Thomas P ^d   Orsini, Joseph J ^h   Pellegrino, Joan E ^m   Provenzale, James M ^j   Wenger, David A ⁿ   Caggana, Michele ^h   more..

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f CHILDREN S HOSPITAL OF BUFFALO   (United States)

^g NewYork Presbyterian Hospital   (United States)

^h WADSWORTH CENTER   (United States)

ⁱ NEW YORK MEDICAL COLLEGE   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^m State University of New York Upstate Medical University: College of Medicine   (United States)

ⁿ THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

Globoid cell leukodystrophy; Krabbe disease; newborn screening

Indexed keywords

GALACTOSYLCERAMIDASE;

ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CLINICAL OUTCOME; DISEASE SEVERITY; DRIED BLOOD SPOT TESTING; GLOBOID CELL LEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK INFANT; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; NEW YORK; NEWBORN; NEWBORN SCREENING; SCORING SYSTEM; ADVERSE EFFECTS; FEMALE; GENETICS; INFANT; LEUKODYSTROPHY, GLOBOID CELL; MASS SCREENING; MORTALITY; RISK FACTOR;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKODYSTROPHY, GLOBOID CELL; MASS SCREENING; NEONATAL SCREENING; NEW YORK; RISK FACTORS;

EID: 85000868706     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2016.35     Document Type: Article

References (30)

1. Krabbe K. A new familial infantile form of diffuse brain-sclerosis. Brain 1916;39:74-114.
2. Suzuki K, Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci USA 1970;66: 302-309.
3. Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL. Early infantile Krabbe disease: results of the World-Wide Krabbe Registry. Pediatr Neurol 2011;45:141-148.
4. Hagberg B, Sourander P, Svennerholm L. Diagnosis of Krabbe's infantile leucodystrophy. J Neurol Neurosurg Psychiatry 1963;26:195-198.
5. Duffner PK, Barczykowski A, Kay DM, et al. Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatr Neurol 2012;46: 298-306.
6. Wenger D, Escolar ML, Luzi P, Rafi MA. Krabbe disease (globoid cell leukodystrophy). In: Valle D, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, (eds). The Online Metabolic, Molecular Bases of Inherited Diseases. McGraw-Hill: New York, 2013. http://www.ommbid.com/. Accessed May 2015.
7. Lyon G, Hagberg B, Evrard P, Allaire C, Pavone L, Vanier M. Symptomatology of late onset Krabbe's leukodystrophy: the European experience. Dev Neurosci 1991;13:240-244.
8. Bajaj NP, Waldman A, Orrell R, Wood NW, Bhatia KP. Familial adult onset of Krabbe's disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry 2002;72:635-638.
9. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005;352: 2069-2081.
10. Duffner PK, Caggana M, Orsini JJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol 2009;40:245-52; discussion 253.
11. Orsini JJK, Saavedra-Matiz CA, Wenger DA, et al.; New York State Krabbe Consortium. Newborn screening for Krabbe disease in New York State: the first eight years' experience. Genet Med 2016;18:239-248.
12. Orsini JJ, Morrissey MA, Slavin LN, et al. Implementation of newborn screening for Krabbe disease: population study, cutoff determination. Clin Biochem 2009;42:877-884.
13. Wenger D, Williams C. Screening for lysosomal disorders. In: Hommes F (ed). Techniques in Diagnostic Human Biochemical Genetics. A Laboratory Manual. Wiley-Liss: New York, 1991:587-617.
14. Kemper AR, Knapp AA, Green NS, Comeau AM, Metterville DR, Perrin JM. Weighing the evidence for newborn screening for early-infantile Krabbe disease. Genet Med 2010;12:539-543.
15. Ellis WG, Schneider EL, McCulloch JR, Suzuki K, Epstein CJ. Fetal globoid cell leukocystrophy (Krabbe disease). Pathological, biochemical examination. Arch Neurol 1973;29:253-257.
16. Okeda R, Suzuki Y, Horiguchi S, Fujii T. Fetal globoid cell leukodystrophy in one of twins. Acta Neuropathol 1979;47:151-154.
17. Martin JJ, Leroy JG, Ceuterick C, Libert J, Dodinval P, Martin L. Fetal Krabbe leukodystrophy. A morphologic study of two cases. Acta Neuropathol 1981;53:87-91.
18. Duffner PK, Caviness VS Jr, Erbe RW, et al. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11, 12, 2008, Holiday Valley, New York. Genet Med 2009;11:450-454.
19. Allewelt HB, Page K, Taskindoust M, et al. Long-term functional outcomes following hematopoietic stem cell transplantation for Krabbe disease. Biol Blood Marrow Transplant 2016.
20. Escolar ML, Kurtzberg, J. Long term outcomes of patients with infantile Krabbe disease transplanted in the first months of life before symptoms develop. http://links.lww.com/A844.2009. Accessed September 2015.
21. Salveson R. Expansion of the New York State Newborn Screening Panel, Krabbe Disease: a systematic program evaluation. PhD thesis, Columbia University: New York, 2011.
22. Wilson JM, Jungner YG. [Principles, practice of mass screening for disease]. Bol Oficina Sanit Panam 1968;65:281-393.
23. American College of Medical Genetics Newborn Screening Expert G. Newborn screening: toward a uniform screening panel, system-executive summary. Pediatrics 2006;117:S296-S307.
24. Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic, clinical implications. Hum Mutat 1997;10:268-279.
25. Turgeon CT, Orsini JJ, Sanders KA, et al. Measurement of psychosine in dried blood spots-A possible improvement to newborn screening programs for Krabbe disease. J Inherit Metab Dis 2015;38:923-929.
26. Escolar ML, Poe MD, Smith JK, et al. Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease. AJNR Am J Neuroradiol 2009;30:1017-1021.
27. Alpern G. Developmental Profile 3. Western Psychological Services: 2007 WPS: Torrance, CA.
28. Centers for Disease Control, Prevention (CDC) Growth Charts. 2000. http://www.cdc.gov/growthcharts/cdc-charts.htm. Accessed September 2015.
29. PediTools. http://peditools.org/. Accessed September 2015.
30. Nellhaus G. Head circumference from birth to eighteen years. Practical composite international, interracial graphs. Pediatrics 1968;41:106-114.